CDEX Granted Notice of Allowance for U.S. Patent Application Covering Identification and Determination of Chemical Substances Using Enhanced Photoemission Spectroscopy
Marketwire - Thu Jul 31, 7:30AM CDT
CDEX Inc. (OTCBB: CDEX) (OTCQB: CDEX), a pioneering developer, manufacturer and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets, today announced that the U.S. Patent and Trademark Office has granted a Notice of Allowance for U.S. Patent Application No. 13/673,270 with claims that cover methods for identifying and determining unknown substances using enhanced photoemission spectroscopy ("EPS"
CDEX Completes Shipment of 10 ValiMed CCT Systems Ahead of Schedule
Marketwire - Mon Mar 25, 8:30AM CDT
CDEX Inc. (OTCQB: CDEX), a leading developer of chemical detection products using patented technologies for use in healthcare, safety and security markets, today announced the company completed and shipped the 10 unit order of its ValiMed(TM) CCT drug validation system to Al-Essa Medical & Scientific Equipment Company in Safat, Kuwait ahead of schedule. The shipment completes the sale secured in December of 2012. The units will be placed in service at medical facilities throughout the region along with testing supplies for initial operation. Each unit placed requires additional service for installation and ongoing product support by CDEX for two years from the date of delivery.